Pluripotency transcription factor function during primordial germ cell development
Pluripotency transcription factor function during primordial germ cell development
批准号:
BB/L002736/1
负责人:
Ian Chambers
金额:
$58.79万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2014
资助国家:
英国
项目状态:
已结题
起止时间:
2014 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The aim of the proposed work is to study the factors regulating formation of functional germ cells, oocytes in females and sperm in males. We will focus on the role of Nanog, an important molecule involved at distinct stages during embryonic development.We will determine what parts of Nanog are required to mediate function in developing primordial germ cells (PGCs for short), the embryonic cells that will give rise to the adult germ cells. We will compare Nanog proteins from different species for their ability to function in mouse cells, since the mouse is the mammalian species where these processes are best understood. We will investigate whether Nanog function is unique, or whether other factors, such as Esrrb, can play a similar role in PGCs. We will determine how Nanog exerts its function in driving germ cell development by identifying the genes regulated by Nanog in this process.This study will delineate the mechanisms through which Nanog functions. We will learn if Nanog function has been conserved throughout evolution and which parts of the Nanog molecule are important. In a broader sense, since primordial germ cells and the cells of the early embryo that retain unrestricted differentiation potential are similar, we will understand better how the factors required for the formation of these distinct cells work. Understanding how functional germ cells are formed is of great importance for the progress of reproductive medicine. Learning how pluripotent cells are regulated has high impact on regenerative medicine strategies. The continued existence of a sexually reproducing species requires effective formation of germ cells that possess a haploid DNA complement and that can join with another germ cell of the opposite sex during fertilisation to form a new individual. PGC development from cells set aside early in development involves changes in gene expression and modifications of the chromatin, the complex of DNA and protein in which the genome is packed, as the PGCs migrate to the site where the genitals form, known as the genital ridges. Once the PGCs enter the genital ridges they undergo further changes to their chromatin that erase memories of their parental origin. This sets a blank slate onto which instructions for gene expression in the next generation can be written. These changes are directed by a number of important factors able to influence the expression of other genes, amongst which is Nanog. We have shown that Nanog is required for continued PGC development during the period of chromatin remodelling. Interestingly, Nanog is also required at the other developmental period in which profound chromatin remodelling occurs; the formation of cells with unrestricted differentiation potential (pluripotency) in the pre-implantation embryo. Pluripotency can be conveniently studied in cells grown in culture and derived from pre-implantation embryos: embryonic stem (ES) cells. Nanog controls the ability of ES cells to indefinitely duplicate. Our recent work has characterized the genes acting downstream of Nanog in ES cells. We consistently found that the gene most up-regulated by Nanog induction was Esrrb. We further showed that Esrrb could recapitulate many of the functional properties previously ascribed to Nanog and, importantly could do this in the absence of Nanog. A further key finding is that, in ES cells lacking Esrrb, the ability of Nanog to sustain pluripotency is compromised. This demonstrates unequivocally that Esrrb is a critical downstream mediator of Nanog function in ES cells.We now propose to investigate in greater detail the importance of Nanog function in germ cell development and determine whether a similar functional relationship exists between Nanog and Esrrb in PGCs. Our study has the potential to highlight new similarities between the pluripotent cells of the pre-implantation embryo and PGCs, ultimately improving our understanding of the principles governing both cell populations.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Differential repression of Otx2 underlies the capacity of NANOG and ESRRB to induce germline entry
Otx2 的差异抑制是 NANOG 和 ESRRB 诱导种系进入能力的基础
DOI:
10.1101/2021.06.14.448276
发表时间:
2021
期刊:
影响因子:
--
作者:
[Vojtek M]
通讯作者:
Vojtek M
DOI:
10.1016/j.jmb.2016.12.001
发表时间:
2017-05-19
期刊:
Journal of molecular biology
影响因子:
5.6
作者:
[Mullin NP, Gagliardi A, Khoa LTP, Colby D, Hall-Ponsele E, Rowe AJ, Chambers I]
通讯作者:
Chambers I
OTX2 restricts entry to the mouse germline.
OTX2限制了进入鼠标种系的输入。
DOI:
10.1038/s41586-018-0581-5
发表时间:
2018-10
期刊:
Nature
影响因子:
64.8
作者:
[Zhang J, Zhang M, Acampora D, Vojtek M, Yuan D, Simeone A, Chambers I]
通讯作者:
Chambers I
Esrrb Complementation Rescues Development of Nanog-Null Germ Cells.
ESRRB互补挽救了纳米无效生殖细胞的发展。
DOI:
10.1016/j.celrep.2017.12.060
发表时间:
2018-01-09
期刊:
Cell reports
影响因子:
8.8
作者:
[Zhang M, Leitch HG, Tang WWC, Festuccia N, Hall-Ponsele E, Nichols J, Surani MA, Smith A, Chambers I]
通讯作者:
Chambers I
DOI:
10.1016/j.stemcr.2021.11.013
发表时间:
2022-01-11
期刊:
Stem cell reports
影响因子:
5.9
作者:
[Vojtek M, Zhang J, Sun J, Zhang M, Chambers I]
通讯作者:
Chambers I
A direct biochemical connection between the pluripotency regulator, NANOG and RNA Polymerase II
-
批准号:BB/T008644/1
-
项目类别:Research Grant
-
资助金额:$85.61万
-
财政年份:2020
-
负责人:Ian Chambers
-
依托单位:
Transcription factor control of dynamic transitions within and beyond pluripotency
-
批准号:MR/T003162/1
-
项目类别:Research Grant
-
资助金额:$260.77万
-
财政年份:2019
-
负责人:Ian Chambers
-
依托单位:
STARR-seq Analysis of Enhancer Function in Mouse Pluripotent Cells
-
批准号:BB/R019274/1
-
项目类别:Research Grant
-
资助金额:$90.22万
-
财政年份:2018
-
负责人:Ian Chambers
-
依托单位:
Japan Partnering Award: Gene regulatory networks in stem cells and primordial germ cells
-
批准号:BB/N022599/1
-
项目类别:Research Grant
-
资助金额:$6.0万
-
财政年份:2016
-
负责人:Ian Chambers
-
依托单位:
Dynamic transcription factor function in control of pluripotent cell sub-states
-
批准号:MR/L018497/1
-
项目类别:Research Grant
-
资助金额:$227.57万
-
财政年份:2014
-
负责人:Ian Chambers
-
依托单位:
Transcription factor dynamics in control of pluripotent cell function and identity
-
批准号:G0901533/1
-
项目类别:Research Grant
-
资助金额:$133.38万
-
财政年份:2011
-
负责人:Ian Chambers
-
依托单位:
国内基金
海外基金
登录
查看更多内容
转录因子BCL6抑制ICOSL表达优化生发中心反应的机制研究
-
批准号:82371745
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:张文倩
-
依托单位:
转录因子LEF1低表达抑制HMGB1致子宫腺肌病患者子宫内膜容受性低下的分子机制
-
批准号:82371704
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:徐步芳
-
依托单位:
小鼠肺腺鳞癌转分化类器官模型的建立及表观调控分子机制研究
-
批准号:32100593
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:童欣媛
-
依托单位:
NFATc3转录调控MMP14介导少突胶质细胞瘤血管新生促肿瘤恶变的机制研究
-
批准号:32100563
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:齐琳
-
依托单位:
KLF5诱导小鼠始发态多能性干细胞向滋养层干细胞转变的作用与机制研究
-
批准号:32100596
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:黄颖华
-
依托单位:
锌指蛋白ZBTB17调控成纤维细胞衰老的机制研究
-
批准号:32000509
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:马兴杰
-
依托单位:
细胞衰老抑制直接重编程及心肌再生修复的分子机理研究
-
批准号:92068107
-
项目类别:重大研究计划
-
资助金额:79.0万元
-
批准年份:2020
-
负责人:王丽
-
依托单位:
转录因子SALL4通过影响pre-mRNA可变剪接调控非Yamanaka因子体细胞重编程的机制研究
-
批准号:32000502
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:王波
-
依托单位:
DNA糖苷酶OGG1调节PARP1介导的EB病毒潜伏蛋白表达的机制研究
-
批准号:32000546
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:郝文静
-
依托单位:
CD10蛋白N-糖基化修饰介导PI3Kα活化诱导细胞衰老的分子机制研究
-
批准号:32000508
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:刘雪玲
-
依托单位: